# Corning Inc: financial statements, quarterly GLW · NYSE · CIK 24741 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/glw.md) · [Financials](/companies/glw/financials.md) · [Filings](/companies/glw/filings.md) · [Insiders](/companies/glw/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/glw/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [3,173](/filings/0001437749-24-032912.md) | [2,994 d](/filings/0000024741-26-000124.md) | [2,975](/filings/0001628280-25-021711.md) | [3,251](/filings/0001628280-25-037169.md) | [3,391](/filings/0000024741-25-000121.md) | [3,501 d](/filings/0000024741-26-000124.md) | [3,452](/filings/0000024741-26-000205.md) | [3,862](/filings/0000024741-26-000255.md) | [4,100](/filings/0000024741-25-000121.md) | [4,215 d](/filings/0000024741-26-000124.md) | [4,144](/filings/0000024741-26-000205.md) | [4,505](/filings/0000024741-26-000255.md) | | Cost of revenue | $m | [2,169](/filings/0001437749-24-032912.md) | [2,083 d](/filings/0000024741-26-000124.md) | [1,982](/filings/0001628280-25-021711.md) | [2,302](/filings/0001628280-25-037169.md) | [2,254](/filings/0000024741-25-000121.md) | [2,304 d](/filings/0000024741-26-000124.md) | [2,238](/filings/0000024741-26-000205.md) | [2,470](/filings/0000024741-26-000255.md) | [2,580](/filings/0000024741-25-000121.md) | [2,720 d](/filings/0000024741-26-000124.md) | [2,616](/filings/0000024741-26-000205.md) | [2,877](/filings/0000024741-26-000255.md) | | Gross profit | $m | [1,004](/filings/0001437749-24-032912.md) | [911 d](/filings/0000024741-26-000124.md) | [993](/filings/0001628280-25-021711.md) | [949](/filings/0001628280-25-037169.md) | [1,137](/filings/0000024741-25-000121.md) | [1,197 d](/filings/0000024741-26-000124.md) | [1,214](/filings/0000024741-26-000205.md) | [1,392](/filings/0000024741-26-000255.md) | [1,520](/filings/0000024741-25-000121.md) | [1,495 d](/filings/0000024741-26-000124.md) | [1,528](/filings/0000024741-26-000205.md) | [1,628](/filings/0000024741-26-000255.md) | | Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Selling, general and administrative | $m | [468](/filings/0001437749-24-032912.md) | [514 d](/filings/0000024741-26-000124.md) | [451](/filings/0001628280-25-021711.md) | [471](/filings/0001628280-25-037169.md) | [510](/filings/0000024741-25-000121.md) | [499 d](/filings/0000024741-26-000124.md) | [471](/filings/0000024741-26-000205.md) | [515](/filings/0000024741-26-000255.md) | [624](/filings/0000024741-25-000121.md) | [512 d](/filings/0000024741-26-000124.md) | [588](/filings/0000024741-26-000205.md) | [608](/filings/0000024741-26-000255.md) | | Operating income | $m | [236](/filings/0001437749-24-032912.md) | [78.0 d](/filings/0000024741-26-000124.md) | [254](/filings/0001628280-25-021711.md) | [186](/filings/0001628280-25-037169.md) | [302](/filings/0000024741-25-000121.md) | [393 d](/filings/0000024741-26-000124.md) | [445](/filings/0000024741-26-000205.md) | [573](/filings/0000024741-26-000255.md) | [589](/filings/0000024741-25-000121.md) | [672 d](/filings/0000024741-26-000124.md) | [639](/filings/0000024741-26-000205.md) | [698](/filings/0000024741-26-000255.md) | | Interest expense | $m | not reported | not reported | [83.0](/filings/0001628280-25-021711.md) | [84.0](/filings/0001628280-25-037169.md) | [83.0](/filings/0000024741-25-000121.md) | [79.0 d](/filings/0000024741-26-000124.md) | [82.0](/filings/0000024741-26-000205.md) | [83.0](/filings/0000024741-26-000255.md) | [78.0](/filings/0000024741-25-000121.md) | [93.0 d](/filings/0000024741-26-000124.md) | [92.0](/filings/0000024741-26-000205.md) | [94.0](/filings/0000024741-26-000255.md) | | Income tax | $m | [35.0](/filings/0001437749-24-032912.md) | [(10.0) d](/filings/0000024741-26-000124.md) | [71.0](/filings/0001628280-25-021711.md) | [50.0](/filings/0001628280-25-037169.md) | [3.0](/filings/0000024741-25-000121.md) | [97.0 d](/filings/0000024741-26-000124.md) | [55.0](/filings/0000024741-26-000205.md) | [84.0](/filings/0000024741-26-000255.md) | [80.0](/filings/0000024741-25-000121.md) | [91.0 d](/filings/0000024741-26-000124.md) | [121](/filings/0000024741-26-000205.md) | [40.0](/filings/0000024741-26-000255.md) | | Net income | $m | [164](/filings/0001437749-24-032912.md) | [(40.0) d](/filings/0000024741-26-000124.md) | [209](/filings/0001628280-25-021711.md) | [104](/filings/0001628280-25-037169.md) | [(117)](/filings/0000024741-25-000121.md) | [310 d](/filings/0000024741-26-000124.md) | [157](/filings/0000024741-26-000205.md) | [469](/filings/0000024741-26-000255.md) | [430](/filings/0000024741-25-000121.md) | [540 d](/filings/0000024741-26-000124.md) | [371](/filings/0000024741-26-000205.md) | [559](/filings/0000024741-26-000255.md) | | Diluted EPS | $ per share | [0.19](/filings/0001437749-24-032912.md) | not reported | [0.24](/filings/0001628280-25-021711.md) | [0.12](/filings/0001628280-25-037169.md) | [(0.14)](/filings/0000024741-25-000121.md) | not reported | [0.18](/filings/0000024741-26-000205.md) | [0.54](/filings/0000024741-26-000255.md) | [0.50](/filings/0000024741-25-000121.md) | not reported | [0.43](/filings/0000024741-26-000205.md) | [0.64](/filings/0000024741-26-000255.md) | | Basic EPS | $ per share | [0.19](/filings/0001437749-24-032912.md) | not reported | [0.25](/filings/0001628280-25-021711.md) | [0.12](/filings/0001628280-25-037169.md) | [(0.14)](/filings/0000024741-25-000121.md) | not reported | [0.18](/filings/0000024741-26-000205.md) | [0.55](/filings/0000024741-26-000255.md) | [0.50](/filings/0000024741-25-000121.md) | not reported | [0.43](/filings/0000024741-26-000205.md) | [0.65](/filings/0000024741-26-000255.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: not reported - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | not reported | [1.8](/filings/0000024741-26-000124.md) | not reported | not reported | not reported | [1.8](/filings/0000024741-26-000124.md) | [1.4](/filings/0000024741-26-000205.md) | [1.5](/filings/0000024741-26-000255.md) | not reported | [1.5](/filings/0000024741-26-000255.md) | [1.8](/filings/0000024741-26-000205.md) | [2.5](/filings/0000024741-26-000255.md) | | Current assets | $bn | [7.3](/filings/0001437749-23-029347.md) | [7.2](/filings/0001628280-25-005347.md) | [7.0](/filings/0001437749-24-014319.md) | [7.1](/filings/0001437749-24-024494.md) | [7.7](/filings/0001437749-24-032912.md) | [8.0](/filings/0000024741-26-000124.md) | [7.6](/filings/0001628280-25-021711.md) | [8.2](/filings/0001628280-25-037169.md) | [8.7](/filings/0000024741-25-000121.md) | [8.9](/filings/0000024741-26-000255.md) | [9.5](/filings/0000024741-26-000205.md) | [10.9](/filings/0000024741-26-000255.md) | | Total assets | $bn | [28.3](/filings/0001437749-23-029347.md) | [28.5](/filings/0000024741-26-000124.md) | [27.6](/filings/0001437749-24-014319.md) | [27.2](/filings/0001437749-24-024494.md) | [28.3](/filings/0001437749-24-032912.md) | [27.7](/filings/0000024741-26-000124.md) | [27.4](/filings/0001628280-25-021711.md) | [28.7](/filings/0001628280-25-037169.md) | [29.9](/filings/0000024741-25-000121.md) | [31.0](/filings/0000024741-26-000255.md) | [31.3](/filings/0000024741-26-000205.md) | [33.0](/filings/0000024741-26-000255.md) | | Current liabilities | $bn | [4.3](/filings/0001437749-23-029347.md) | [4.3](/filings/0001628280-25-005347.md) | [4.2](/filings/0001437749-24-014319.md) | [4.5](/filings/0001437749-24-024494.md) | [4.6](/filings/0001437749-24-032912.md) | [4.9](/filings/0000024741-26-000124.md) | [4.5](/filings/0001628280-25-021711.md) | [5.5](/filings/0001628280-25-037169.md) | [5.6](/filings/0000024741-25-000121.md) | [5.6](/filings/0000024741-26-000255.md) | [5.9](/filings/0000024741-26-000205.md) | [6.0](/filings/0000024741-26-000255.md) | | Total liabilities | $bn | [16.5](/filings/0001437749-23-029347.md) | [16.6](/filings/0001628280-25-005347.md) | [16.1](/filings/0001437749-24-014319.md) | [16.3](/filings/0001437749-24-024494.md) | [16.9](/filings/0001437749-24-032912.md) | [16.7](/filings/0000024741-26-000124.md) | [16.3](/filings/0001628280-25-021711.md) | [17.2](/filings/0001628280-25-037169.md) | [17.9](/filings/0000024741-25-000121.md) | [18.7](/filings/0000024741-26-000255.md) | [18.9](/filings/0000024741-26-000205.md) | [19.8](/filings/0000024741-26-000255.md) | | Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $bn | [0.3](/filings/0001437749-23-029347.md) | [0.3](/filings/0001628280-25-005347.md) | [0.3](/filings/0001437749-24-014319.md) | [0.4](/filings/0001437749-24-024494.md) | [0.3](/filings/0001437749-24-032912.md) | [0.3](/filings/0000024741-26-000124.md) | [0.3](/filings/0001628280-25-021711.md) | [0.8](/filings/0001628280-25-037169.md) | [0.8](/filings/0000024741-25-000121.md) | [0.8](/filings/0000024741-26-000255.md) | [1.3](/filings/0000024741-26-000205.md) | [0.7](/filings/0000024741-26-000255.md) | | Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $bn | [11.4](/filings/0001437749-23-029347.md) | [11.6](/filings/0001628280-25-005347.md) | [11.2](/filings/0001437749-24-014319.md) | [10.6](/filings/0001437749-24-024494.md) | [11.1](/filings/0001437749-24-032912.md) | [10.7](/filings/0000024741-26-000124.md) | [10.7](/filings/0001628280-25-021711.md) | [11.1](/filings/0001628280-25-037169.md) | [11.5](/filings/0000024741-25-000121.md) | [11.8](/filings/0000024741-26-000255.md) | [11.8](/filings/0000024741-26-000205.md) | [12.6](/filings/0000024741-26-000255.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: us-gaap:DebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [722 d](/filings/0001437749-24-032912.md) | [713 d](/filings/0000024741-26-000124.md) | [96.0](/filings/0001628280-25-021711.md) | [521 d](/filings/0001628280-25-037169.md) | [699 d](/filings/0000024741-25-000121.md) | [623 d](/filings/0000024741-26-000124.md) | [151](/filings/0000024741-26-000205.md) | [708 d](/filings/0000024741-26-000255.md) | [784 d](/filings/0000024741-25-000121.md) | [1,052 d](/filings/0000024741-26-000124.md) | [362](/filings/0000024741-26-000205.md) | [1,717 d](/filings/0000024741-26-000255.md) | | Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | not reported | not reported | not reported | not reported | [30.0 d](/filings/0000024741-25-000121.md) | [30.0 d](/filings/0000024741-26-000124.md) | [100](/filings/0000024741-26-000205.md) | [33.0 d](/filings/0000024741-26-000255.md) | [25.0 d](/filings/0000024741-25-000121.md) | [5.0 d](/filings/0000024741-26-000124.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: not reported - Dividends paid: not reported - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [855](/filings/0001437749-23-029347.md) | [859](/filings/0001437749-24-014319.md) | [859](/filings/0001437749-24-024494.md) | [859](/filings/0001437749-24-032912.md) | [862](/filings/0001628280-25-021711.md) | [864](/filings/0001628280-25-037169.md) | [854](/filings/0000024741-25-000121.md) | [866](/filings/0000024741-26-000205.md) | [865](/filings/0000024741-26-000255.md) | [868](/filings/0000024741-25-000121.md) | [871](/filings/0000024741-26-000205.md) | [875](/filings/0000024741-26-000255.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 861,388,331 at 2026-07-24, from the cover of the [10-Q filed 2026-07-29](/filings/0000024741-26-000255.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.